Search Results

You are looking at 1 - 10 of 173 items for :

  • "ulcerative colitis" x
  • Refine by Access: All Content x
Clear All

6102 6108 Travis, S. P. L., Stange, E. F., Lémann, M. és mtsai: European evidence-based consensus on the management of ulcerative colitis, current management. J

Open access

11 7525 7530 Jantchou, P., Monnet, E., Carbonnel, F.: Environmental risk factors in Crohn’s disease and ulcerative colitis (excluding

Restricted access

., Papadakis, K. A.: Visilizumab induces apoptosis of mucosal T-lymphocytes in ulcerative colitis through activation of caspase 3 and 8 dependent pathways. Clin. Immunol., 2008, 127 , 322–329. Papadakis K. A

Open access
Orvosi Hetilap
Authors: Renáta Bor, Klaudia Farkas, Anita Bálint, Tibor Wittmann, Ferenc Nagy, László Tiszlavicz, Tamás Molnár, and Zoltán Szepes

Barreiro, P., Pinto Marques, P., Couto, G., et al.: Autoimmune pancreatitis and ulcerative colitis: A clinical challenge of a true association. GE J. Port. Gastrenterol., 2013, 20, 36

Restricted access
Orvosi Hetilap
Authors: Péter László Lakatos and László Lakatos

European Federation of Crohn’s and Ulcerative Colitis Associations: Results from the EFCCA Pan-European survey of Crohn’s disease and ulcerative colitis patients. Available at http://www.efcca.org/final_pan_eu_survey_fact_sheet.pdf , 2005

Restricted access

Kornbluth, A., Sachar, D. B.: Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am. J. Gastroenterol., 2004, 99

Restricted access
Acta Microbiologica et Immunologica Hungarica
Authors: Fahimeh Sadat Gholam-Mostafaei, Abbas Yadegar, Hamid Asadzadeh Aghdaei, Shabnam Shahrokh, Nasser Ebrahimi Daryani, and Mohammad Reza Zali

Introduction Inflammatory bowel disease (IBD), is a chronic and relapsing non-specific inflammatory intestinal disease including ulcerative colitis (UC) and Crohn's disease (CD), which is hallmarked by a disturbance in

Restricted access
Hungarian Medical Journal
Authors: Joye Varghese, K. R. Mohan, I. Haseeb, K. Krishnaprasad, A. Sundaram, and V. Jayanthi

Sood, A., Midha, V., Sood, N. et al.: Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut, 2003, 52 , 1587–1590. Sood N. Incidence and prevalence of

Restricted access

Abstract  

Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD) in which there is recurrent inflammation of the mucous membranes of the colon. Inflammation is accompanied by the production of reactive oxygen species (ROS) including, amongst others, hydrogen peroxide. Selenium in the form of the selenoprotein glutathione peroxidase (GSH-Px) acts as a catalyst in the reaction which reduces hydrogen peroxide to water. It may therefore beneficial to supplement the diets of patients who suffer from UC with selenium. In this preliminary study nine patients suffering from moderate UC were supplemented with selenium- tablets (300 g Se per tablet) twice daily. Blood samples were taken at the start of the trial and at 1, 2 and 4 week intervals. Freeze-dried serum samples were analysed for their selenium content using the technique of instrumental neutron activation analysis (INAA). Samples were also analysed by particle induced X-ray emission (PIXE) to monitor other trace elements levels. Selenium concentrations were found to increase during supplementation and iron concentrations to decrease. Stool frequency was also found to improve suggesting that ROS may be important in the pathogenesis of UC.

Restricted access
Orvosi Hetilap
Authors: Mariann Rutka, Anita Bálint, Klaudia Farkas, Károly Palatka, Lilla Lakner, Pál Miheller, István Rácz, Gábor Hegede, Áron Vincze, Gábor Horváth, Andrea Szabó, Ferenc Nagy, Zoltán Szepes, Zoltán Gábor, Ferenc Zsigmond, Ágnes Zsóri, Márk Juhász, Ágnes Csontos, Mónika Szűcs, Renáta Bor, Ágnes Milassin, and Tamás Molnár

References 1 Solberg, I. C., Lygren, I., Jahnsen, J., et al.: Clinical course during the first 10 years of ulcerative colitis: results from a population

Open access